表紙
市場調查報告書

單株抗體的全球市場

Monoclonal Antibodies

出版商 Global Industry Analysts, Inc. 商品編碼 912648
出版日期 內容資訊 英文 349 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
單株抗體的全球市場 Monoclonal Antibodies
出版日期: 2019年10月01日內容資訊: 英文 349 Pages
簡介

本報告提供全球單株抗體的市場相關分析,彙整整體市場規模的實際成果值·預測值,及主要推動及阻礙市場要素,不同症狀·各原料·各用途及各企業的市場佔有率趨勢 (過去9年·今後8年份),今後的市場成長的方向性,各地區·主要國家的市場詳細趨勢等調查,主要企業的簡介等資訊,為您概述為以下內容。

第1章 簡介,分析方法·範圍

第2章 摘要整理

  • 市場概要
    • 各企業的市場佔有率結構 (最新值·預測值)
  • 代表性企業分析
  • 市場趨勢與促進因素
  • 全球市場的未來展望
    • 市場規模·佔有率趨勢預測:各地區/各國
    • 不同症狀 (感染疾病,癌症,微生物疾病等)
    • 各原料 (人體化抗體,人抗體,嵌合抗體,鼠標抗體)
    • 各用途 (診斷用,治療用等)
      • 市場規模:各地區/各國 (過去9年·今後8年份)
      • 市場佔有率:各地區/各國 (總計17年份)

第3章 市場分析

  • 各地區的市場分析
  • 美國
    • 市場基本資料
    • 各企業市場佔有率
    • 單株抗體的市場規模 (實際成果值·預測值)
    • 不同症狀的市場規模 (實際成果值·預測值)
    • 各原料的市場規模 (實際成果值·預測值)
  • 加拿大
  • 日本
  • 中國
  • 歐洲 (法國,德國,義大利,英國,西班牙,俄羅斯等)
  • 亞太地區 (澳洲,印度,韓國等)
  • 南美 (阿根廷,巴西,墨西哥等)
  • 中東 (伊朗,以色列,沙烏地阿拉伯,UAE等)
  • 非洲

第4章 企業

  • ABBOTT DIAGNOSTICS, INC. - CORE LABORATORY
  • ABBVIE
  • AMGEN
  • ASTRAZENECA PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • JOHNSON & JOHNSON
  • MERCK & CO., INC.
  • NOVARTIS INTERNATIONAL AG

第5章 相關分析

目錄
Product Code: MCP-3411

Monoclonal Antibodies market worldwide is projected to grow by US$47.6 Billion, driven by a compounded growth of 6%. Inflammatory Disease, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$44.3 Billion by the year 2025, Inflammatory Disease will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 5.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.7 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.5 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Inflammatory Disease will reach a market size of US$2.1 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 8.9% over the next couple of years and add approximately US$12.9 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Abbott Diagnostics, Inc. - Core Laboratory; AbbVie, Inc.; Amgen, Inc.; AstraZeneca PLC; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche AG; Johnson & Johnson; Merck & Co., Inc.; Novartis International AG

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Monoclonal Antibodies Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Monoclonal Antibodies Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Monoclonal Antibodies Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Monoclonal Antibodies Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Inflammatory Disease (Indication) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Inflammatory Disease (Indication) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Inflammatory Disease (Indication) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Cancer (Indication) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Cancer (Indication) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Cancer (Indication) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Microbial Disease (Indication) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Microbial Disease (Indication) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Microbial Disease (Indication) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Other Indications (Indication) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Other Indications (Indication) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Other Indications (Indication) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Humanized (Source) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Humanized (Source) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Humanized (Source) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Human (Source) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 20: Human (Source) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 21: Human (Source) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 22: Chimeric (Source) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025
  • TABLE 23: Chimeric (Source) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017
  • TABLE 24: Chimeric (Source) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 25: Murine (Source) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 26: Murine (Source) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 27: Murine (Source) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 28: Diagnostic (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 29: Diagnostic (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 30: Diagnostic (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 31: Therapeutic (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025
  • TABLE 32: Therapeutic (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 33: Therapeutic (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 34: Other Applications (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 35: Other Applications (Application) Global Historic Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 36: Other Applications (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Monoclonal Antibodies Market Share (in %) by Company: 2019 & 2025
    • TABLE 37: United States Monoclonal Antibodies Market Estimates and Projections in US$ Million by Indication: 2018 to 2025
    • TABLE 38: Monoclonal Antibodies Market in the United States by Indication: A Historic Review in US$ Million for 2009-2017
    • TABLE 39: United States Monoclonal Antibodies Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
    • TABLE 40: United States Monoclonal Antibodies Market Estimates and Projections in US$ Million by Source: 2018 to 2025
    • TABLE 41: Monoclonal Antibodies Market in the United States by Source: A Historic Review in US$ Million for 2009-2017
    • TABLE 42: United States Monoclonal Antibodies Market Share Breakdown by Source: 2009 VS 2019 VS 2025
    • TABLE 43: United States Monoclonal Antibodies Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
    • TABLE 44: Monoclonal Antibodies Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017
    • TABLE 45: Monoclonal Antibodies Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 46: Canadian Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2018 to 2025
    • TABLE 47: Canadian Monoclonal Antibodies Historic Market Review by Indication in US$ Million: 2009-2017
    • TABLE 48: Monoclonal Antibodies Market in Canada: Percentage Share Breakdown of Sales by Indication for 2009, 2019, and 2025
    • TABLE 49: Canadian Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2018 to 2025
    • TABLE 50: Canadian Monoclonal Antibodies Historic Market Review by Source in US$ Million: 2009-2017
    • TABLE 51: Monoclonal Antibodies Market in Canada: Percentage Share Breakdown of Sales by Source for 2009, 2019, and 2025
    • TABLE 52: Canadian Monoclonal Antibodies Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
    • TABLE 53: Monoclonal Antibodies Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
    • TABLE 54: Canadian Monoclonal Antibodies Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • JAPAN
    • TABLE 55: Japanese Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2018-2025
    • TABLE 56: Monoclonal Antibodies Market in Japan: Historic Sales Analysis in US$ Million by Indication for the Period 2009-2017
    • TABLE 57: Japanese Monoclonal Antibodies Market Share Analysis by Indication: 2009 VS 2019 VS 2025
    • TABLE 58: Japanese Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Source for the Period 2018-2025
    • TABLE 59: Monoclonal Antibodies Market in Japan: Historic Sales Analysis in US$ Million by Source for the Period 2009-2017
    • TABLE 60: Japanese Monoclonal Antibodies Market Share Analysis by Source: 2009 VS 2019 VS 2025
    • TABLE 61: Japanese Demand Estimates and Forecasts for Monoclonal Antibodies in US$ Million by Application: 2018 to 2025
    • TABLE 62: Japanese Monoclonal Antibodies Market in US$ Million by Application: 2009-2017
    • TABLE 63: Monoclonal Antibodies Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 64: Chinese Monoclonal Antibodies Market Growth Prospects in US$ Million by Indication for the Period 2018-2025
    • TABLE 65: Monoclonal Antibodies Historic Market Analysis in China in US$ Million by Indication: 2009-2017
    • TABLE 66: Chinese Monoclonal Antibodies Market by Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 67: Chinese Monoclonal Antibodies Market Growth Prospects in US$ Million by Source for the Period 2018-2025
    • TABLE 68: Monoclonal Antibodies Historic Market Analysis in China in US$ Million by Source: 2009-2017
    • TABLE 69: Chinese Monoclonal Antibodies Market by Source: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 70: Chinese Demand for Monoclonal Antibodies in US$ Million by Application: 2018 to 2025
    • TABLE 71: Monoclonal Antibodies Market Review in China in US$ Million by Application: 2009-2017
    • TABLE 72: Chinese Monoclonal Antibodies Market Share Breakdown by Application: 2009 VS 2019 VS 2025
  • EUROPE
    • Market Facts & Figures
    • European Monoclonal Antibodies Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 73: European Monoclonal Antibodies Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 74: Monoclonal Antibodies Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 75: European Monoclonal Antibodies Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 76: European Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2018-2025
    • TABLE 77: Monoclonal Antibodies Market in Europe in US$ Million by Indication: A Historic Review for the Period 2009-2017
    • TABLE 78: European Monoclonal Antibodies Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
    • TABLE 79: European Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2018-2025
    • TABLE 80: Monoclonal Antibodies Market in Europe in US$ Million by Source: A Historic Review for the Period 2009-2017
    • TABLE 81: European Monoclonal Antibodies Market Share Breakdown by Source: 2009 VS 2019 VS 2025
    • TABLE 82: European Monoclonal Antibodies Addressable Market Opportunity in US$ Million by Application: 2018-2025
    • TABLE 83: Monoclonal Antibodies Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
    • TABLE 84: European Monoclonal Antibodies Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 85: Monoclonal Antibodies Market in France by Indication: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 86: French Monoclonal Antibodies Historic Market Scenario in US$ Million by Indication: 2009-2017
    • TABLE 87: French Monoclonal Antibodies Market Share Analysis by Indication:
  • 2009 VS 2019 VS 2025
    • TABLE 88: Monoclonal Antibodies Market in France by Source: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 89: French Monoclonal Antibodies Historic Market Scenario in US$ Million by Source: 2009-2017
    • TABLE 90: French Monoclonal Antibodies Market Share Analysis by Source: 2009 VS 2019 VS 2025
    • TABLE 91: Monoclonal Antibodies Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025
    • TABLE 92: French Monoclonal Antibodies Historic Market Review in US$ Million by Application: 2009-2017
    • TABLE 93: French Monoclonal Antibodies Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
  • GERMANY
    • TABLE 94: Monoclonal Antibodies Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025
    • TABLE 95: German Monoclonal Antibodies Historic Market Analysis in US$ Million by Indication: 2009-2017
    • TABLE 96: German Monoclonal Antibodies Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
    • TABLE 97: Monoclonal Antibodies Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Source for the Period 2018-2025
    • TABLE 98: German Monoclonal Antibodies Historic Market Analysis in US$ Million by Source: 2009-2017
    • TABLE 99: German Monoclonal Antibodies Market Share Breakdown by Source: 2009 VS 2019 VS 2025
    • TABLE 100: Monoclonal Antibodies Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
    • TABLE 101: German Monoclonal Antibodies Market in Retrospect in US$ Million by Application: 2009-2017
    • TABLE 102: Monoclonal Antibodies Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 103: Italian Monoclonal Antibodies Market Growth Prospects in US$ Million by Indication for the Period 2018-2025
    • TABLE 104: Monoclonal Antibodies Historic Market Analysis in Italy in US$ Million by Indication: 2009-2017
    • TABLE 105: Italian Monoclonal Antibodies Market by Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 106: Italian Monoclonal Antibodies Market Growth Prospects in US$ Million by Source for the Period 2018-2025
    • TABLE 107: Monoclonal Antibodies Historic Market Analysis in Italy in US$ Million by Source: 2009-2017
    • TABLE 108: Italian Monoclonal Antibodies Market by Source: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 109: Italian Demand for Monoclonal Antibodies in US$ Million by Application: 2018 to 2025
    • TABLE 110: Monoclonal Antibodies Market Review in Italy in US$ Million by Application: 2009-2017
    • TABLE 111: Italian Monoclonal Antibodies Market Share Breakdown by Application: 2009 VS 2019 VS 2025
  • UNITED KINGDOM
    • TABLE 112: United Kingdom Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2018-2025
    • TABLE 113: Monoclonal Antibodies Market in the United Kingdom: Historic Sales Analysis in US$ Million by Indication for the Period 2009-2017
    • TABLE 114: United Kingdom Monoclonal Antibodies Market Share Analysis by Indication: 2009 VS 2019 VS 2025
    • TABLE 115: United Kingdom Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Source for the Period 2018-2025
    • TABLE 116: Monoclonal Antibodies Market in the United Kingdom: Historic Sales Analysis in US$ Million by Source for the Period 2009-2017
    • TABLE 117: United Kingdom Monoclonal Antibodies Market Share Analysis by Source: 2009 VS 2019 VS 2025
    • TABLE 118: United Kingdom Demand Estimates and Forecasts for Monoclonal Antibodies in US$ Million by Application: 2018 to 2025
    • TABLE 119: United Kingdom Monoclonal Antibodies Market in US$ Million by Application: 2009-2017
    • TABLE 120: Monoclonal Antibodies Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 121: Spanish Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2018 to 2025
    • TABLE 122: Spanish Monoclonal Antibodies Historic Market Review by Indication in US$ Million: 2009-2017
    • TABLE 123: Monoclonal Antibodies Market in Spain: Percentage Share Breakdown of Sales by Indication for 2009, 2019, and 2025
    • TABLE 124: Spanish Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2018 to 2025
    • TABLE 125: Spanish Monoclonal Antibodies Historic Market Review by Source in US$ Million: 2009-2017
    • TABLE 126: Monoclonal Antibodies Market in Spain: Percentage Share Breakdown of Sales by Source for 2009, 2019, and 2025
    • TABLE 127: Spanish Monoclonal Antibodies Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
    • TABLE 128: Monoclonal Antibodies Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
    • TABLE 129: Spanish Monoclonal Antibodies Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • RUSSIA
    • TABLE 130: Russian Monoclonal Antibodies Market Estimates and Projections in US$ Million by Indication: 2018 to 2025
    • TABLE 131: Monoclonal Antibodies Market in Russia by Indication: A Historic Review in US$ Million for 2009-2017
    • TABLE 132: Russian Monoclonal Antibodies Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
    • TABLE 133: Russian Monoclonal Antibodies Market Estimates and Projections in US$ Million by Source: 2018 to 2025
    • TABLE 134: Monoclonal Antibodies Market in Russia by Source: A Historic Review in US$ Million for 2009-2017
    • TABLE 135: Russian Monoclonal Antibodies Market Share Breakdown by Source: 2009 VS 2019 VS 2025
    • TABLE 136: Russian Monoclonal Antibodies Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
    • TABLE 137: Monoclonal Antibodies Historic Demand Patterns in Russia by Application in US$ Million for 2009-2017
    • TABLE 138: Monoclonal Antibodies Market Share Breakdown in Russia by Application: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 139: Rest of Europe Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2018-2025
    • TABLE 140: Monoclonal Antibodies Market in Rest of Europe in US$ Million by Indication: A Historic Review for the Period 2009-2017
    • TABLE 141: Rest of Europe Monoclonal Antibodies Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
    • TABLE 142: Rest of Europe Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2018-2025
    • TABLE 143: Monoclonal Antibodies Market in Rest of Europe in US$ Million by Source: A Historic Review for the Period 2009-2017
    • TABLE 144: Rest of Europe Monoclonal Antibodies Market Share Breakdown by Source: 2009 VS 2019 VS 2025
    • TABLE 145: Rest of Europe Monoclonal Antibodies Addressable Market Opportunity in US$ Million by Application: 2018-2025
    • TABLE 146: Monoclonal Antibodies Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
    • TABLE 147: Rest of Europe Monoclonal Antibodies Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 148: Asia-Pacific Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 149: Monoclonal Antibodies Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 150: Asia-Pacific Monoclonal Antibodies Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 151: Monoclonal Antibodies Market in Asia-Pacific by Indication: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 152: Asia-Pacific Monoclonal Antibodies Historic Market Scenario in US$ Million by Indication: 2009-2017
    • TABLE 153: Asia-Pacific Monoclonal Antibodies Market Share Analysis by Indication: 2009 VS 2019 VS 2025
    • TABLE 154: Monoclonal Antibodies Market in Asia-Pacific by Source: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 155: Asia-Pacific Monoclonal Antibodies Historic Market Scenario in US$ Million by Source: 2009-2017
    • TABLE 156: Asia-Pacific Monoclonal Antibodies Market Share Analysis by Source: 2009 VS 2019 VS 2025
    • TABLE 157: Monoclonal Antibodies Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025
    • TABLE 158: Asia-Pacific Monoclonal Antibodies Historic Market Review in US$ Million by Application: 2009-2017
    • TABLE 159: Asia-Pacific Monoclonal Antibodies Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
  • AUSTRALIA
    • TABLE 160: Monoclonal Antibodies Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025
    • TABLE 161: Australian Monoclonal Antibodies Historic Market Analysis in US$ Million by Indication: 2009-2017
    • TABLE 162: Australian Monoclonal Antibodies Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
    • TABLE 163: Monoclonal Antibodies Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Source for the Period 2018-2025
    • TABLE 164: Australian Monoclonal Antibodies Historic Market Analysis in US$ Million by Source: 2009-2017
    • TABLE 165: Australian Monoclonal Antibodies Market Share Breakdown by Source: 2009 VS 2019 VS 2025
    • TABLE 166: Monoclonal Antibodies Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
    • TABLE 167: Australian Monoclonal Antibodies Market in Retrospect in US$ Million by Application: 2009-2017
    • TABLE 168: Monoclonal Antibodies Market Share Distribution in Australia by Application: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 169: Indian Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2018 to 2025
    • TABLE 170: Indian Monoclonal Antibodies Historic Market Review by Indication in US$ Million: 2009-2017
    • TABLE 171: Monoclonal Antibodies Market in India: Percentage Share Breakdown of Sales by Indication for 2009, 2019, and 2025
    • TABLE 172: Indian Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2018 to 2025
    • TABLE 173: Indian Monoclonal Antibodies Historic Market Review by Source in US$ Million: 2009-2017
    • TABLE 174: Monoclonal Antibodies Market in India: Percentage Share Breakdown of Sales by Source for 2009, 2019, and 2025
    • TABLE 175: Indian Monoclonal Antibodies Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
    • TABLE 176: Monoclonal Antibodies Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
    • TABLE 177: Indian Monoclonal Antibodies Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • SOUTH KOREA
    • TABLE 178: Monoclonal Antibodies Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025
    • TABLE 179: South Korean Monoclonal Antibodies Historic Market Analysis in US$ Million by Indication: 2009-2017
    • TABLE 180: Monoclonal Antibodies Market Share Distribution in South Korea by Indication: 2009 VS 2019 VS 2025
    • TABLE 181: Monoclonal Antibodies Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Source for the Period 2018-2025
    • TABLE 182: South Korean Monoclonal Antibodies Historic Market Analysis in US$ Million by Source: 2009-2017
    • TABLE 183: Monoclonal Antibodies Market Share Distribution in South Korea by Source: 2009 VS 2019 VS 2025
    • TABLE 184: Monoclonal Antibodies Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2018-2025
    • TABLE 185: South Korean Monoclonal Antibodies Historic Market Analysis in US$ Million by Application: 2009-2017
    • TABLE 186: Monoclonal Antibodies Market Share Distribution in South Korea by Application: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 187: Rest of Asia-Pacific Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2018-2025
    • TABLE 188: Monoclonal Antibodies Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Indication for the Period 2009-2017
    • TABLE 189: Rest of Asia-Pacific Monoclonal Antibodies Market Share Analysis by Indication: 2009 VS 2019 VS 2025
    • TABLE 190: Rest of Asia-Pacific Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Source for the Period 2018-2025
    • TABLE 191: Monoclonal Antibodies Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Source for the Period 2009-2017
    • TABLE 192: Rest of Asia-Pacific Monoclonal Antibodies Market Share Analysis by Source: 2009 VS 2019 VS 2025
    • TABLE 193: Rest of Asia-Pacific Demand Estimates and Forecasts for Monoclonal Antibodies in US$ Million by Application: 2018 to 2025
    • TABLE 194: Rest of Asia-Pacific Monoclonal Antibodies Market in US$ Million by Application: 2009-2017
    • TABLE 195: Monoclonal Antibodies Market Share Shift in Rest of Asia-Pacific by Application: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 196: Latin American Monoclonal Antibodies Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 197: Monoclonal Antibodies Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 198: Latin American Monoclonal Antibodies Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 199: Latin American Monoclonal Antibodies Market Growth Prospects in US$ Million by Indication for the Period 2018-2025
    • TABLE 200: Monoclonal Antibodies Historic Market Analysis in Latin America in US$ Million by Indication: 2009-2017
    • TABLE 201: Latin American Monoclonal Antibodies Market by Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 202: Latin American Monoclonal Antibodies Market Growth Prospects in US$ Million by Source for the Period 2018-2025
    • TABLE 203: Monoclonal Antibodies Historic Market Analysis in Latin America in US$ Million by Source: 2009-2017
    • TABLE 204: Latin American Monoclonal Antibodies Market by Source: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 205: Latin American Demand for Monoclonal Antibodies in US$ Million by Application: 2018 to 2025
    • TABLE 206: Monoclonal Antibodies Market Review in Latin America in US$ Million by Application: 2009-2017
    • TABLE 207: Latin American Monoclonal Antibodies Market Share Breakdown by Application: 2009 VS 2019 VS 2025
  • ARGENTINA
    • TABLE 208: Argentinean Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2018-2025
    • TABLE 209: Monoclonal Antibodies Market in Argentina in US$ Million by Indication: A Historic Review for the Period 2009-2017
    • TABLE 210: Argentinean Monoclonal Antibodies Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
    • TABLE 211: Argentinean Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2018-2025
    • TABLE 212: Monoclonal Antibodies Market in Argentina in US$ Million by Source: A Historic Review for the Period 2009-2017
    • TABLE 213: Argentinean Monoclonal Antibodies Market Share Breakdown by Source: 2009 VS 2019 VS 2025
    • TABLE 214: Argentinean Monoclonal Antibodies Addressable Market Opportunity in US$ Million by Application: 2018-2025
    • TABLE 215: Monoclonal Antibodies Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
    • TABLE 216: Argentinean Monoclonal Antibodies Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 217: Monoclonal Antibodies Market in Brazil by Indication: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 218: Brazilian Monoclonal Antibodies Historic Market Scenario in US$ Million by Indication: 2009-2017
    • TABLE 219: Brazilian Monoclonal Antibodies Market Share Analysis by Indication: 2009 VS 2019 VS 2025
    • TABLE 220: Monoclonal Antibodies Market in Brazil by Source: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 221: Brazilian Monoclonal Antibodies Historic Market Scenario in US$ Million by Source: 2009-2017
    • TABLE 222: Brazilian Monoclonal Antibodies Market Share Analysis by Source: 2009 VS 2019 VS 2025
    • TABLE 223: Monoclonal Antibodies Quantitative Demand Analysis in Brazil in US$ Million by Application: 2018-2025
    • TABLE 224: Brazilian Monoclonal Antibodies Historic Market Review in US$ Million by Application: 2009-2017
    • TABLE 225: Brazilian Monoclonal Antibodies Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
  • MEXICO
    • TABLE 226: Monoclonal Antibodies Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025
    • TABLE 227: Mexican Monoclonal Antibodies Historic Market Analysis in US$ Million by Indication: 2009-2017
    • TABLE 228: Mexican Monoclonal Antibodies Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
    • TABLE 229: Monoclonal Antibodies Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Source for the Period 2018-2025
    • TABLE 230: Mexican Monoclonal Antibodies Historic Market Analysis in US$ Million by Source: 2009-2017
    • TABLE 231: Mexican Monoclonal Antibodies Market Share Breakdown by Source: 2009 VS 2019 VS 2025
    • TABLE 232: Monoclonal Antibodies Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
    • TABLE 233: Mexican Monoclonal Antibodies Market in Retrospect in US$ Million by Application: 2009-2017
    • TABLE 234: Monoclonal Antibodies Market Share Distribution in Mexico by Application: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 235: Rest of Latin America Monoclonal Antibodies Market Estimates and Projections in US$ Million by Indication: 2018 to 2025
    • TABLE 236: Monoclonal Antibodies Market in Rest of Latin America by Indication: A Historic Review in US$ Million for 2009-2017
    • TABLE 237: Rest of Latin America Monoclonal Antibodies Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
    • TABLE 238: Rest of Latin America Monoclonal Antibodies Market Estimates and Projections in US$ Million by Source: 2018 to 2025
    • TABLE 239: Monoclonal Antibodies Market in Rest of Latin America by Source: A Historic Review in US$ Million for 2009-2017
    • TABLE 240: Rest of Latin America Monoclonal Antibodies Market Share Breakdown by Source: 2009 VS 2019 VS 2025
    • TABLE 241: Rest of Latin America Monoclonal Antibodies Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
    • TABLE 242: Monoclonal Antibodies Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2009-2017
    • TABLE 243: Monoclonal Antibodies Market Share Breakdown in Rest of Latin America by Application: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 244: The Middle East Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 245: Monoclonal Antibodies Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 246: The Middle East Monoclonal Antibodies Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 247: The Middle East Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2018 to 2025
    • TABLE 248: The Middle East Monoclonal Antibodies Historic Market by Indication in US$ Million: 2009-2017
    • TABLE 249: Monoclonal Antibodies Market in the Middle East: Percentage Share Breakdown of Sales by Indication for 2009, 2019, and 2025
    • TABLE 250: The Middle East Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2018 to 2025
    • TABLE 251: The Middle East Monoclonal Antibodies Historic Market by Source in US$ Million: 2009-2017
    • TABLE 252: Monoclonal Antibodies Market in the Middle East: Percentage Share Breakdown of Sales by Source for 2009, 2019, and 2025
    • TABLE 253: The Middle East Monoclonal Antibodies Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
    • TABLE 254: Monoclonal Antibodies Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
    • TABLE 255: The Middle East Monoclonal Antibodies Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • IRAN
    • TABLE 256: Iranian Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2018-2025
    • TABLE 257: Monoclonal Antibodies Market in Iran: Historic Sales Analysis in US$ Million by Indication for the Period 2009-2017
    • TABLE 258: Iranian Monoclonal Antibodies Market Share Analysis by Indication: 2009 VS 2019 VS 2025
    • TABLE 259: Iranian Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Source for the Period 2018-2025
    • TABLE 260: Monoclonal Antibodies Market in Iran: Historic Sales Analysis in US$ Million by Source for the Period 2009-2017
    • TABLE 261: Iranian Monoclonal Antibodies Market Share Analysis by Source: 2009 VS 2019 VS 2025
    • TABLE 262: Iranian Demand Estimates and Forecasts for Monoclonal Antibodies in US$ Million by Application: 2018 to 2025
    • TABLE 263: Iranian Monoclonal Antibodies Market in US$ Million by Application: 2009-2017
    • TABLE 264: Monoclonal Antibodies Market Share Shift in Iran by Application: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 265: Israeli Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2018-2025
    • TABLE 266: Monoclonal Antibodies Market in Israel in US$ Million by Indication: A Historic Review for the Period 2009-2017
    • TABLE 267: Israeli Monoclonal Antibodies Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
    • TABLE 268: Israeli Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2018-2025
    • TABLE 269: Monoclonal Antibodies Market in Israel in US$ Million by Source: A Historic Review for the Period 2009-2017
    • TABLE 270: Israeli Monoclonal Antibodies Market Share Breakdown by Source: 2009 VS 2019 VS 2025
    • TABLE 271: Israeli Monoclonal Antibodies Addressable Market Opportunity in US$ Million by Application: 2018-2025
    • TABLE 272: Monoclonal Antibodies Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
    • TABLE 273: Israeli Monoclonal Antibodies Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 274: Saudi Arabian Monoclonal Antibodies Market Growth Prospects in US$ Million by Indication for the Period 2018-2025
    • TABLE 275: Monoclonal Antibodies Historic Market Analysis in Saudi Arabia in US$ Million by Indication: 2009-2017
    • TABLE 276: Saudi Arabian Monoclonal Antibodies Market by Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 277: Saudi Arabian Monoclonal Antibodies Market Growth Prospects in US$ Million by Source for the Period 2018-2025
    • TABLE 278: Monoclonal Antibodies Historic Market Analysis in Saudi Arabia in US$ Million by Source: 2009-2017
    • TABLE 279: Saudi Arabian Monoclonal Antibodies Market by Source: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 280: Saudi Arabian Demand for Monoclonal Antibodies in US$ Million by Application: 2018 to 2025
    • TABLE 281: Monoclonal Antibodies Market Review in Saudi Arabia in US$ Million by Application: 2009-2017
    • TABLE 282: Saudi Arabian Monoclonal Antibodies Market Share Breakdown by Application: 2009 VS 2019 VS 2025
  • UNITED ARAB EMIRATES
    • TABLE 283: Monoclonal Antibodies Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025
    • TABLE 284: United Arab Emirates Monoclonal Antibodies Historic Market Analysis in US$ Million by Indication: 2009-2017
    • TABLE 285: Monoclonal Antibodies Market Share Distribution in United Arab Emirates by Indication: 2009 VS 2019 VS 2025
    • TABLE 286: Monoclonal Antibodies Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Source for the Period 2018-2025
    • TABLE 287: United Arab Emirates Monoclonal Antibodies Historic Market Analysis in US$ Million by Source: 2009-2017
    • TABLE 288: Monoclonal Antibodies Market Share Distribution in United Arab Emirates by Source: 2009 VS 2019 VS 2025
    • TABLE 289: Monoclonal Antibodies Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2018-2025
    • TABLE 290: United Arab Emirates Monoclonal Antibodies Historic Market Analysis in US$ Million by Application: 2009-2017
    • TABLE 291: Monoclonal Antibodies Market Share Distribution in United Arab Emirates by Application: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 292: Monoclonal Antibodies Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025
    • TABLE 293: Rest of Middle East Monoclonal Antibodies Historic Market Analysis in US$ Million by Indication: 2009-2017
    • TABLE 294: Rest of Middle East Monoclonal Antibodies Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
    • TABLE 295: Monoclonal Antibodies Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Source for the Period 2018-2025
    • TABLE 296: Rest of Middle East Monoclonal Antibodies Historic Market Analysis in US$ Million by Source: 2009-2017
    • TABLE 297: Rest of Middle East Monoclonal Antibodies Market Share Breakdown by Source: 2009 VS 2019 VS 2025
    • TABLE 298: Monoclonal Antibodies Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
    • TABLE 299: Rest of Middle East Monoclonal Antibodies Market in Retrospect in US$ Million by Application: 2009-2017
    • TABLE 300: Monoclonal Antibodies Market Share Distribution in Rest of Middle East by Application: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 301: African Monoclonal Antibodies Market Estimates and Projections in US$ Million by Indication: 2018 to 2025
    • TABLE 302: Monoclonal Antibodies Market in Africa by Indication: A Historic Review in US$ Million for 2009-2017
    • TABLE 303: African Monoclonal Antibodies Market Share Breakdown by Indication: 2009 VS 2019 VS 2025
    • TABLE 304: African Monoclonal Antibodies Market Estimates and Projections in US$ Million by Source: 2018 to 2025
    • TABLE 305: Monoclonal Antibodies Market in Africa by Source: A Historic Review in US$ Million for 2009-2017
    • TABLE 306: African Monoclonal Antibodies Market Share Breakdown by Source: 2009 VS 2019 VS 2025
    • TABLE 307: African Monoclonal Antibodies Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
    • TABLE 308: Monoclonal Antibodies Historic Demand Patterns in Africa by Application in US$ Million for 2009-2017
    • TABLE 309: Monoclonal Antibodies Market Share Breakdown in Africa by Application: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ABBOTT DIAGNOSTICS, INC. - CORE LABORATORY
  • ABBVIE
  • AMGEN
  • ASTRAZENECA PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • JOHNSON & JOHNSON
  • MERCK & CO., INC.
  • NOVARTIS INTERNATIONAL AG

V. CURATED RESEARCH

Back to Top